Ex-Adaptive CFO Schorno Resurfaces Quickly At 23andMe

Dean Schorno has joined 23andMe, a genetic information company with drug development aspirations, as its chief financial officer and head of operations. Schorno was previously at Seattle’s Adaptive Biotechnologies for a year and before that at Bay Area diagnostics company Genomic Health. Adaptive said last week that Chad Cohen would replace Schorno as CFO.

Trending on Xconomy